AEROMAX

Manufacturer Cathay YSS
Distributor Cathay YSS
Contents Montelukast Na
Indications Management of chronic asthma & allergic rhinitis; prophylaxis for exercise-induced asthma.
Dosage Adult 10 mg. Childn 6-14 yr 5 mg, 2-5 yr 4 mg. All doses to be taken once daily in the evening.
Administration May be taken with or without food.
Contraindications Hypersensitivity.
Special Precautions Systemic eosinophilia may occur. Avoid abrupt substitution to inhaled or oral corticosteroids. Concomitant use w/ NSAIDs in patients w/ known aspirin sensitivity. Not for treatment of acute asthma attacks. Pregnancy & lactation.
Side Effects / Adverse Reactions Headache, dizziness; abdominal pain, dyspepsia, infectious gastroenteritis; influenza, cough, nasal congestion; fatigue, dental pain, rash, fever, trauma.

 

Drug Interactions Potent hepatic enzyme inducers eg phenytoin, phenobarb or rifampicin.
Pregnancy Category (US FDA) Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1sttrimester (and there is no evidence of a risk in later trimesters).
Therapeutic Class Antiasthmatic & COPD Preparations
ATC Classification R03DC03 – montelukast ; Belongs to the class of leukotriene receptor antagonists. Used in the systemic treatment of obstructive airway diseases.
Regulatory Classification Rx

Related Articles

ORPHENADRINE + PARACETAMOL

Orphenadrine, a tertiary amine antimuscarinic, is an indirect skeletal muscle stimulator with central atropine-like actions. It also has some local [...]

VACCINE, INFLUENZA

Influenza vaccine boosts protection against the influenza virus by stimulating the development of particular antibodies. Use this medication precisely as [...]

VACCINE, HUMAN PAPILLOMAVIRUS TYPES 16 AND 18 (RECOMBINANT)

Human Papillomavirus (HPV) bivalent vaccine is a non-infectious adjuvanted vaccination created by recombinant technology. It includes non-active virus-like particles (VLP) [...]